These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37300554)

  • 1. Successful treatment of refractory enteritis and arthritis with combination of tumour necrosis factor and interleukin-6 inhibition in patients with ulcerative colitis.
    Ishigaki S; Kondo Y; Ota Y; Chu PS; Hanaoka H; Takeuchi T; Kaneko Y
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):33-36. PubMed ID: 37300554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerative colitis-related postoperative enteritis treated with anti-tumor necrosis factor therapy: two case reports and a literature review.
    Shimoda F; Kuroha M; Chiba H; Abe I; Yano K; Inomata Y; Takahashi T; Shimoyama Y; Moroi R; Shiga H; Kakuta Y; Fujishima F; Masamune A
    Clin J Gastroenterol; 2021 Oct; 14(5):1396-1403. PubMed ID: 34302278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice.
    Marutani Y; Mizoshita T; Sugiyama T; Togawa S; Katano T; Yamada T; Hirata Y; Kimura Y; Miyaki T; Inoue Y; Suzuki E; Sasaki M; Kataoka H
    Indian J Gastroenterol; 2020 Dec; 39(6):565-575. PubMed ID: 33106991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective use of switching biologics for ulcerative colitis complicated with pyoderma gangrenosum and primary sclerosing cholangitis.
    Iwahashi K; Kuroki Y; Takano Y; Nagahama M
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33958364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: two case reports.
    Momen Majumder MS; Haq SA; Rasker JJ
    J Med Case Rep; 2023 Mar; 17(1):71. PubMed ID: 36855206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials.
    Lopez A; Ford AC; Colombel JF; Reinisch W; Sandborn WJ; Peyrin-Biroulet L
    Dig Liver Dis; 2015 May; 47(5):356-64. PubMed ID: 25661014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
    Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
    World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report.
    Alhalabi M; Eddin KA; Cheha K; Abbas A
    Medicine (Baltimore); 2021 Sep; 100(38):e27283. PubMed ID: 34559136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Successful treatment of ulcerative colitis-related post-colectomy enteritis refractory to multiple therapies with ustekinumab.
    Guo C; He S; Wang H
    Front Immunol; 2024; 15():1297508. PubMed ID: 38433841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-TNFα Treatment in Children and Adolescents With Combined Inflammatory Bowel Disease and Autoimmune Liver Disease.
    Nedelkopoulou N; Vadamalayan B; Vergani D; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):100-105. PubMed ID: 28953529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
    Hoentjen F; Hanauer SB; Hart J; Rubin DT
    J Clin Gastroenterol; 2013 Jan; 47(1):52-7. PubMed ID: 22858512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse enteritis after colectomy for ulcerative colitis: two case reports and review of the literature.
    Corporaal S; Karrenbeld A; van der Linde K; Voskuil JH; Kleibeuker JH; Dijkstra G
    Eur J Gastroenterol Hepatol; 2009 Jun; 21(6):710-5. PubMed ID: 19282770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.
    Atreya R; Billmeier U; Rath T; Mudter J; Vieth M; Neumann H; Neurath MF
    World J Gastroenterol; 2015 Dec; 21(45):12963-9. PubMed ID: 26668517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tofacitinib in a patient with inflammatory bowel disease-related arthritis.
    Lomborg N; Jensen MD
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):171-172. PubMed ID: 35260908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcerative colitis associated enteritis: is ulcerative colitis always confined to the colon?
    Rubenstein J; Sherif A; Appelman H; Chey WD
    J Clin Gastroenterol; 2004 Jan; 38(1):46-51. PubMed ID: 14679327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcerative enteritis. How the extension of ulcerative colitis to small bowel may jeopardize postcolectomy course: a case report and literature review.
    Gonella F; Massucco P; Daperno M; Mineccia M; Perotti S; Rocca R; Ferrero A
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):589-594. PubMed ID: 33657604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Golimumab for moderately to severely active ulcerative colitis.
    Kedia S; Ahuja V; Makharia GK
    Expert Rev Clin Pharmacol; 2016 Oct; 9(10):1273-82. PubMed ID: 27498886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab.
    Duca I; Ramírez de la Piscina P; Estrada S; Calderón R; Spicakova K; Urtasun L; Marra-López C; Zabaleta S; Bengoa R; Marcaide MA; García-Campos F
    World J Gastroenterol; 2013 Jan; 19(4):590-3. PubMed ID: 23382642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
    Lawson MM; Thomas AG; Akobeng AK
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.